Blueprint Medicines Corporation
BPMC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $496 | -$49,956 | -$56,274 | -$49,994 |
| Dep. & Amort. | $1,127 | $4,001 | $3,863 | $3,617 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $29,056 | $28,382 | $28,282 | $28,022 |
| Change in WC | $0 | -$10,138 | $15,464 | -$26,808 |
| Other Non-Cash | -$85,158 | -$1,653 | -$4,972 | -$2,909 |
| Operating Cash Flow | -$54,479 | -$29,364 | -$13,637 | -$48,072 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,831 | -$932 | -$25 | -$2,569 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$283,327 | -$209,769 | -$201,024 | -$355,473 |
| Inv. Sales/Matur. | $350,237 | $244,410 | $231,000 | $169,750 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $65,079 | $33,709 | $29,951 | -$188,292 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $541 | $0 | $146,801 |
| Stock Issued | $0 | $0 | -$98,543 | $31,211 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,192 | $9,218 | $18,377 | $31,211 |
| Financing Cash Flow | $9,192 | $9,759 | $18,377 | $178,012 |
| Forex Effect | $661 | -$1,324 | $591 | -$31 |
| Net Chg. in Cash | $20,453 | $12,780 | $46,088 | -$58,555 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $113,639 | $100,859 | $54,771 | $113,326 |
| End Cash | $134,092 | $113,639 | $100,859 | $54,771 |
| Free Cash Flow | -$56,310 | -$30,296 | -$13,662 | -$50,641 |